- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT00007748
Exercise and Behavioral Therapy Trial (EBT).
CSP#470 - A Randomized, Multi-Center, Controlled Trial of Multi-Modal Therapy in Veterans With Gulf War Illnesses
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Primary Hypothesis:
The primary hypothesis is that both aerobic exercise and cognitive behavioral therapy (CBT) will significantly improve physical function (as measured by the Physical Component Summary Scale of the SF-36V) in veterans with Gulf War Veterans' Illnesses (GWVI), and the combination of cognitive behavioral therapy and aerobic exercise will be more beneficial than either therapy alone.
Secondary Hypotheses:
- Both aerobic exercise and CBT will lead to improvements in the cardinal symptoms of GWVI: pain, fatigue and cognitive difficulties.
- Both aerobic exercise and CBT will lead to decreased levels of distress in persons with GWVI.
- Both aerobic exercise and CBT will lead to improvements in emotional functioning in persons with GWVI.
Primary Outcomes: Improvement on the Physical Component Summary Scale of the SF-36V of more than 7 units at one year relative to baseline.
Interventions: Twelve one-hour weekly sessions of Cognitive behavioral therapy, aerobic exercise, the combination of the two therapies (12 one-hour sessions of CBT and 12 one-hour sessions of aerobic exercise) and a control group that receives usual and customary care.
Study Abstract: This trial was a study of Gulf War era veterans who have unexplained chronic medical symptoms such as pain, fatigue, and/or cognitive difficulties. All Gulf War veterans who were deployed to the South West Asia theater of operations between August 1990 and August 1991 were eligible for the study if they had at least two of the following three symptoms that began after August of 1990, lasting for more than six months and occurring up to present: 1. fatigue that limits usual activities (work, recreation, or social), 2. musculoskeletal pain involving two or more regions of the body, and neuro-cognitive dysfunction (self-reported difficulties in memory, concentration, or attention). Veterans who met enrollment criteria were randomized to one of four treatment arms: 1. CBT plus aerobic exercise, 2. aerobic exercise alone, 3. CBT alone, and 4. usual and customary care. Treatment was given for three months in group format. The CBT and exercise groups met for one hour, once a week for 12 weeks for a total of 12 hourly sessions. The interventions were standardized and all investigators were trained in the use of these methods prior to start up of the trial. The target sample size was 1064 veterans with GWVI to be accrued from 20 Medical Centers (18 VA and 2 DOD). All veterans were followed for one year and outcomes measured at 3 months (immediately following the end of treatment), 6 months and 12 months after enrollment.
The study was kicked-off in April 1999 and enrollment ended on September 5, 2000, during which 1092 veterans were randomized. Patient follow-up concluded on September 30, 2001 and the final DSMB meeting was held on November 28, 2001. The major finding was that there were no significant differences in the proportion of veterans who reported an improvement in physical function at one year among the treatment groups (11.5% for usual care, 11.7% for exercise, 18.4% for CBT and 18.5% for CBT + exercise). However, statistically significant improvements in fatigue, cognitive symptoms, distress, and mental health functioning were observed with exercise alone and with exercise plus CBT compared to usual care. CBT alone had a statistically significant effect on cognitive symptoms and in mental health functioning. Except for affective pain, which improved with CBT alone or with exercise, neither treatment had a significant effect on the other three measures of pain. In summary, neither exercise nor CBT had a significant impact on physical function for veterans with GWVI but both treatments, especially exercise, resulted in improvement in fatigue, cognitive symptoms, distress and mental health functioning.
Results embargoed until publication.
Studientyp
Einschreibung
Phase
- Phase 3
Kontakte und Standorte
Studienorte
-
-
-
San Juan, Puerto Rico, 00921-3201
- San Juan Vamc
-
-
-
-
Alabama
-
Birmingham, Alabama, Vereinigte Staaten, 35233
- Birmingham Vamc
-
Birmingham, Alabama, Vereinigte Staaten, 35233
- Birmingham Vamc Birmingham Vamc
-
-
California
-
San Diego, California, Vereinigte Staaten, 92106-6000
- Naval Health Research Center, San Diego
-
San Diego, California, Vereinigte Staaten, 92152
- Naval Health Research Center, San Diego
-
San Diego, California, Vereinigte Staaten, 92186-5122
- Naval Health Research Center, San Diego
-
San Francisco, California, Vereinigte Staaten, 94121
- San Francisco VAMC
-
-
Connecticut
-
West Haven, Connecticut, Vereinigte Staaten, 06516
- VA CT Healthcare System, West Haven
-
-
District of Columbia
-
Washington, District of Columbia, Vereinigte Staaten, 20007
- Georgetown University Medical Center
-
Washington, District of Columbia, Vereinigte Staaten, 20307-5001
- Walter Reed Army Medical Center
-
-
Maryland
-
Bethesda, Maryland, Vereinigte Staaten, 20814-4799
- Uniformed Services University
-
-
Massachusetts
-
Boston, Massachusetts, Vereinigte Staaten, 02118
- Boston Medical Center
-
Boston, Massachusetts, Vereinigte Staaten, 02130
- Boston Vamc
-
Boston, Massachusetts, Vereinigte Staaten, 02114
- Boston Vamc
-
-
Missouri
-
St. Louis, Missouri, Vereinigte Staaten, 63106
- John Cochran VAMC, Saint Louis
-
-
New Jersey
-
East Orange, New Jersey, Vereinigte Staaten, 07018
- VA New Jersey Health Care System, East Orange
-
-
New Mexico
-
Albuquerque, New Mexico, Vereinigte Staaten, 87108
- Vamc - Albuquerque
-
-
New York
-
Brooklyn, New York, Vereinigte Staaten, 11209
- New York Harbor VA Healthcare System, Brooklyn Campus
-
-
North Dakota
-
Fargo, North Dakota, Vereinigte Staaten, 58102
- Fargo Vamc
-
-
Ohio
-
Dayton, Ohio, Vereinigte Staaten, 45428
- Vamc - Dayton
-
-
Oregon
-
Portland, Oregon, Vereinigte Staaten, 97207
- Portland Vamc
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Vereinigte Staaten, 19104
- Philadelphia Vamc
-
-
Texas
-
Houston, Texas, Vereinigte Staaten, 77030
- Houston VAMC
-
San Antonio, Texas, Vereinigte Staaten, 78284
- Audie L. Murphy Memorial Veterans Hospital, San Antonio
-
-
Vermont
-
Burlington, Vermont, Vereinigte Staaten
- White River Junction VAMC
-
White River Jct., Vermont, Vereinigte Staaten, 05009
- White River Junction VAMC
-
-
Virginia
-
Richmond, Virginia, Vereinigte Staaten, 23249
- Richmond VAMC
-
-
Washington
-
Seattle, Washington, Vereinigte Staaten, 98108-1597
- VA Puget Sound Healthcare System, Seattle Division
-
Seattle, Washington, Vereinigte Staaten, 98108
- VA Puget Sound Healthcare System, Seattle Division
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Fakultätszuweisung
- Maskierung: Keine (Offenes Etikett)
Mitarbeiter und Ermittler
Mitarbeiter
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 470
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .